Protecting Clinical Trial Participants and Protecting Data Integrity: Are We Meeting the Challenges?
Open Access
- 12 June 2012
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 9 (6) , e1001234
- https://doi.org/10.1371/journal.pmed.1001234
Abstract
Susan Ellenberg discusses alternative approaches towards evaluating data as it accumulates in clinical trials, and to protecting the integrity and preventing undue risks to participants, as the trial continues.Keywords
This publication has 32 references indexed in Scilit:
- How local IRBs view central IRBs in the USBMC Medical Ethics, 2011
- Data Safety Monitoring Boards: Legal and Ethical Considerations for Research AccountabilityAccountability in Research, 2010
- Data safety monitoring boards: a word from a sponsor (NHLBI)Transfusion, 2009
- Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring BoardClinical Trials, 2007
- Independence of the statistician who analyses unblinded dataStatistics in Medicine, 2004
- The independent statistician for data monitoring committeesStatistics in Medicine, 2004
- Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?Statistics in Medicine, 2004
- A major trial needs three statisticians: why, how and who?Statistics in Medicine, 2004
- Playing safe and preserving integrity: making the FDA model workStatistics in Medicine, 2004
- Discrete sequential boundaries for clinical trialsBiometrika, 1983